Abortion Drug Restrictions Should Be Lifted, Medical Experts Say

Restrictions surrounding an abortion pill should be lifted, which would provide easier access for pregnant women, because the benefits of mifepristone greatly outweigh the risks, according to a group of medical experts.

Although mifepristone, also known as RU-486, was approved in 2000, it is subject to a Risk Evaluation and Mitigation Strategy (REMS), a set of strict regulations placed on a drug believed to have a limited safety record or that may have serious risks to patients.

But a group of 10 doctors, public health and legal experts, writing in the New England Journal of Medicine, say that decades of experience with mifepristone, both here and abroad, indicate the burdensome regulations are unnecessary and the drug should be made more readily available. They say the REMS should be lifted, given the drug’s track record of very few adverse events.

The drug is available today, but it can only be given to a patient at a clinic or hospital by a certified provider. However, since the number of abortion providers has declined, many women must travel long distances to get the drug.

In addition, the women must be given a medication guide and sign an agreement that they understand mifepristone’s risk. While other drugs, such as antibiotics, insulin and high blood-pressure medication, can cause immediate, serious reactions, they are not subject to the kind of restrictions mifepristone is. The group wants the drug treated like most other FDA-approved medications, so it is available to women with a prescription through a pharmacy.

“The reasons for the REMS are just no longer tenable,” Paul Blumenthal, MD, a professor of obstetrics and gynecology at Stanford School of Medicine who is a member of the group, told Stanford’s Scope Blog. “The drug has proven itself. It can be regulated just like any other drug… If this were Viagra, men would not stand for it.”

Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

No votes so far! Be the first to rate this post.

Latest News

Effects of Vitamin D and Antibiotics during Pregnancy

Effects of Vitamin D and Antibiotics during Pregnancy

A new study out today on Vitamin D and pregnancy plus two more studies on how drugs and supplements given to pregnant women affect the fetus and the offspring for years to come.  Be well.   Bone Density Taking higher doses of Vitamin D during pregnancy showed a correlation with…

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

  • Advertisement